Dacarbazine 500mg
Product Overview
| Generic Name | Dacarbazine 500mg |
| Brand Name(s) | Onecobax, Darbazine; Dazine; |
| Category | Antineoplastic / Cancer |
| Form | Vial, Powder for injection (IV) Vial |
| Strength | 500 mg |
| Therapeutic Class | Chemotherapy (Melanoma, Hodgkin’s lymphoma); second-line soft tissue sarcoma |
| ATC Code | L01AX03 |
Manufacturing & Regulatory
| Manufacturer | Mac-Chem Products (India) Pvt. Ltd., Faulding Pharmaceuticals Plc (UK); generic producers: Alkem, Intas, |
| GMP Compliance | GMP-certified |
| COFEPRIS | No CNIS/Clave assigned |
| Free Sale Certificate | Available from supplier on request |
Logistics & Export
| MOQ | 10 Vials |
| Shelf Life | 24–36 months standard for powder vials |
| Storage | 2–8 °C, protect from light |
| Incoterms | EXW 30049049 |
| Lead Time | 7 - 10 Business Days |
Documentation Available Upon Request
| Certificate of Analysis (PDF) | Provided per batch |
| SDS-Safety Data Sheet (PDF) | Manufacturer provides standard SDS (biologic/aqueous injectable) |
| CTD Summary (PDF) | Public FDA/EMA label/SmPC available; full CTD is not public |
Special Notes
Dacarbazine 500mg Indicated for metastatic melanoma and Hodgkin’s disease. Intravenous alkylating agent used as single-agent therapy in metastatic malignant melanoma and part combination chemotherapyog interference, reducing tumor proliferation.